The cuts hit the FDA's medical device center particularly hard, including reviewers and experts on AI-enabled medical ...
The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...
Scott Gottlieb, the Food and Drug Administration commissioner during the first Trump administration, called for the agency ...
Those laid off Saturday included HHS employees that evaluate the safety of medical devices and conduct oversight of ...
Tech adoption might slow down if the FDA layoffs shift responsibility for medical device and AI safety to hospitals.